It is therefore tempting to speculate that at least in some cancers, GCN2 has a direct or indirect inhibitory effect on MYC, potentially through regulation of one of MYC’s multiple partners (Lourenco et al, 2021). The gene discussed is EIF2AK4; the disease is cancer.